Filing metadata

Accession number
0001140361-23-028539
Form type
Form 4
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Jun 06, 2023
Reporting period
Jun 05, 2023
Description
Insider transaction

Explore SEC Filings Hub